Cover Image
市場調查報告書

美國的整形外科生醫材料市場

Orthopedic Biomaterials | US | 2016 | Market Analysis

出版商 Decision Resources Group - Medtech Solutions 商品編碼 225459
出版日期 內容資訊 英文 167 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的整形外科生醫材料市場 Orthopedic Biomaterials | US | 2016 | Market Analysis
出版日期: 2015年12月22日 內容資訊: 英文 167 Pages
簡介

美國的整形外科生醫材料市場,儘管有受推薦的治療的變更,嚴峻的醫療費償付環境,對產品的負面評價等近幾年的障礙,與其他整形外科市場不同,今後也維持高成長率。

本報告提供美國的整形外科用生醫材料市場相關分析、臨床環境、產品概要、臨床實驗趨勢、主要企業的概要與競爭趨勢、市場趨勢預測 (今後10年份)彙整,為您概述為以下內容。

摘要整理

過去的版本

第1章 整形外科生醫材料市場

  • 市場現狀
  • 市場詳細分析
  • 競爭概要
  • 市場佔有率
  • 近幾年趨勢

第2章 骨移植片替代物的市場

  • 市場現狀
  • 市場詳細分析
    • 各材料
      • 只自體移植片 (治療)
      • 促進成長要素
      • 去礦物質骨基質
      • 整形外科用幹細胞產品
      • (來自其他地方的) 同種異體移植片
      • 第一、第二世代的合成移植片
    • 治療的各類型
      • 脊椎融合
      • 外傷手術
      • 大關節修正、重組
      • 四肢手術
      • 顱顏面手術
  • 競爭概要
  • 更許多競爭環境
  • 市場佔有率

第3章 玻尿酸關節內補充市場

  • 市場現狀
  • 市場詳細分析
    • 各注射回數
    • 人體部位
    • 各設施 (僅定性分析)
  • 競爭概要
  • 更許多競爭環境
  • 市場佔有率

第4章 加工骨椎間設備市場

  • 市場現狀
  • 市場詳細分析
  • 競爭概要
  • 更許多競爭環境
  • 市場佔有率

第5章 細胞濃縮系統市場

  • 市場現狀
  • 市場詳細分析
  • 競爭概要
  • 更許多競爭環境
  • 市場佔有率

附錄:分析方法

附錄:簡稱、詞彙表

附錄:相關分析

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: RPUS20OB15

Despite ongoing obstacles to growth, such as changes to treatment recommendations, challenging reimbursement environments, and negative publicity surrounding significant products, the US market for orthopedic biomaterials will show sustained and improving growth comparable to other large orthopedic markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for orthopedic biomaterials in the US across a 10-year period.

Questions Answered in This Report:

  • The BGS market continues to be negatively impacted by ongoing issues surrounding INFUSE, although the introduction of new products, such as i-Factor and Augment, will help offset this trend.
    • Which material segments will benefit from declining use of growth factor products?
    • How will growth of the overall BGS market be impacted by this change in product mix?
  • The recent and continuing introduction of products and expanded indications in the HA viscosupplementation market will drive market growth.
    • How will the introduction of new products help offset the negative recommendation against HA injections by the AAOS?
    • How will the nonknee market segment expand following the anticipated approval of these indications?
  • Despite a lack of consensus in the clinical data surrounding cell concentration systems, procedure volumes will continue to show moderate growth.
    • Which orthopedic procedure segments generate the highest proportion of cell concentration system unit sales?
    • What strategies are competitors using to expand product penetration and market share in this market?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History

1. Orthopedic Biomaterial Market

  • 1.1. Market Highlights
  • 1.2. Market Definitions
  • 1.3. Market Forecast Data
  • 1.4. General Market Trends
  • 1.5. Competitive Highlights
  • 1.6. Market Shares
  • 1.7. Market Factors and Developments

2. Bone Graft Substitute Market

  • 2.1. Market Highlights
  • 2.2. Market Definitions
  • 2.3. Market Forecast Data
    • 2.3.1. By Material
      • 2.3.1.1. Growth Factors
      • 2.3.1.2. Demineralized Bone Matrices
      • 2.3.1.3. Orthopedic Stem Cell Products
      • 2.3.1.4. Nonproprietary Allografts
      • 2.3.1.5. First- and Second-Generation Synthetics
    • 2.3.2. By Procedure Type
      • 2.3.2.1. Spinal Fusion
        • 2.3.2.1.1. By Approach
        • 2.3.2.1.2. By Anatomy
          • 2.3.2.1.2.1. Thoracolumbar
          • 2.3.2.1.2.2. Cervical
      • 2.3.2.2. Trauma Surgery
      • 2.3.2.3. Large-Joint Revision and Reconstruction
      • 2.3.2.4. Extremity Surgery
      • 2.3.2.5. Craniomaxillofacial Surgery
  • 2.4. General Market Trends
    • 2.4.1. By Material
      • 2.4.1.1. Growth Factors
      • 2.4.1.2. Allografts
      • 2.4.1.3. Synthetics
      • 2.4.1.4. Xenografts
      • 2.4.1.5. Orthopedic Stem Cell
    • 2.4.2. By Procedure Type
      • 2.4.2.1. Spinal Fusion Products
      • 2.4.2.2. Trauma Surgery
      • 2.4.2.3. Large-Joint Revision and Reconstruction
      • 2.4.2.4. Extremity Surgery
      • 2.4.2.5. Craniomaxillofacial Surgery
  • 2.5. Competitive Highlights
  • 2.6. Competitive Landscape
  • 2.7. Market Shares

3. Hyaluronic Acid Viscosupplementation

  • 3.1. Market Highlights
  • 3.2. Market Definitions
  • 3.3. Market Forecast Data
    • 3.3.1. By Number of Injections
    • 3.3.2. By Anatomy
  • 3.4. General Market Trends
  • 3.5. Competitive Highlights
  • 3.6. Competitive Landscape
  • 3.7. Market Shares

4. Cell Concentration System Market

  • 4.1. Market Highlights
  • 4.2. Market Definitions
  • 4.3. Market Forecast Data
  • 4.4. General Market Trends
  • 4.5. Competitive Highlights
  • 4.6. Competitive Landscape
  • 4.7. Market Shares

Appendix: Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

Back to Top